World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
37998
World Ranking
12494
National Ranking
34

Overview

Douglas J. Veale is affiliated with University College Dublin in Ireland and specializes primarily in the field of medicine, with a focus on rheumatology. Their research portfolio spans several interrelated subfields including immunology, pathology and forensic medicine, oncology, and hematology.

The scientist's work covers key topics within autoimmune and inflammatory disorders, with a marked concentration on rheumatoid arthritis research and therapies. Other principal topics include systemic lupus erythematosus, spondyloarthritis studies and treatments, psoriasis pathogenesis and treatment, systemic sclerosis and related diseases, and immune cell function and interaction.

Notable recent papers by Douglas J. Veale include:

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update (2020, Annals of the Rheumatic Diseases)
  • MicroRNA-17-5p Reduces Inflammation and Bone Erosions in Mice With Collagen-Induced Arthritis and Directly Targets the JAK/STAT Pathway in Rheumatoid Arthritis Fibroblast-like Synoviocytes (2020, Arthritis & Rheumatology)
  • The PD-1:PD-L1 axis in Inflammatory Arthritis (2021, BMC Rheumatology)
  • Rheumatoid arthritis CD14+ monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease (2021, Clinical & Translational Immunology)
  • Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications (2022, Nature Reviews Rheumatology)

Douglas J. Veale has frequently published in a number of scholarly venues, including:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Frontiers in Immunology
  • Arthritis Research & Therapy
  • International Journal of Radiation Oncology*Biology*Physics

The work is often conducted in collaboration with other researchers, with frequent co-authors being Ursula Fearon, Mary Canavan, Achilleas Floudas, Kieran Murray, and Viviana Marzaioli.

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • Synovial tissue inflammation in early and late osteoarthritis

    M J Benito;D J Veale;O FitzGerald;W B van den Berg

  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

    L Gossec;J S Smolen;S Ramiro;M de Wit

  • The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography.

    Richard J. Wakefield;Wayne W. Gibbon;Philip G. Conaghan;Philip O'Connor

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

    Laure Gossec;Xenofon Baraliakos;Andreas Kerschbaumer;Maarten de Wit

  • A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

    Rachel K Hoyles;Ross W Ellis;Jessica Wellsbury;Belinda Lees

  • Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    Josef S Smolen;Monika Schöls;Jürgen Braun;Maxime Dougados

  • Hypoxia, oxidative stress and inflammation

    Trudy McGarry;Monika Biniecka;Douglas J. Veale;Ursula Fearon

  • The pathogenesis of psoriatic arthritis.

    Douglas J Veale;Ursula Fearon;Ursula Fearon

  • Recombinant human anti-transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192

    Christopher P. Denton;Peter A. Merkel;Daniel E. Furst;Dinesh Khanna

  • A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

    Laure Gossec;Maarten de Wit;Uta Kiltz;Juergen Braun

  • Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis.

    Ursula Fearon;Mary Canavan;Monika Biniecka;Douglas J. Veale

  • Validation and reproducibility of ultrasonography in the detection of synovitis in the knee-A comparison with arthroscopy and clinical examination

    Z Karim;R J Wakefield;M Quinn;P G Conaghan

  • Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis

    R. J. Reece;J. D. Canete;W. J. Parsons;P. Emery

  • Classification of clinical subsets in psoriatic arthritis.

    D. Veale;S. Rogers;O. Fitzgerald

  • Immunopathology of psoriasis and psoriatic arthritis.

    D J Veale;C Ritchlin;O FitzGerald

  • Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis

    Stephen P. McKenna;Lynda C. Doward;Diane Whalley;Alan Tennant

  • Reduced synovial membrane macrophage numbers, elam-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis

    Douglas Veale;Ghada Yanni;Sarah Rogers;Louise Barnes

  • Angiopoietins, growth factors, and vascular morphology in early arthritis.

    Ursula Fearon;Konstantina Griosios;Alexander Fraser;Richard Reece

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.

    Laura C Coates;Oliver Fitzgerald;Joseph F Merola;Josef Smolen

Frequent Co-Authors

Ursula Fearon
Ursula Fearon Trinity College Dublin
Oliver FitzGerald
Oliver FitzGerald University College Dublin
Barry Bresnihan
Barry Bresnihan University College Dublin
Paul Emery
Paul Emery University of Leeds
Paul P. Tak
Paul P. Tak GlaxoSmithKline (United Kingdom)
John D. Isaacs
John D. Isaacs Newcastle University
Philip S. Helliwell
Philip S. Helliwell University of Leeds
Jill J. F. Belch
Jill J. F. Belch University of Dundee
Robert Landewé
Robert Landewé University of Amsterdam
Iain B. McInnes
Iain B. McInnes University of Glasgow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As interest in medical careers grows, many students are exploring online degree options to start or advance in this rewarding field. Online programs offer flexibility and can help reduce both time and cost barriers for aspiring healthcare professionals.

Among the popular choices are affordable dnp programs. These programs allow registered nurses to earn their Doctor of Nursing Practice with less financial strain, opening doors to advanced clinical and leadership roles.

For those looking to enter the workforce quickly, fast track lpn programs online can be an excellent option. These accelerated pathways enable students to become licensed practical nurses in less time, meeting the demand for frontline healthcare staff.

Mental health continues to be a critical aspect of healthcare. Students interested in this area should consider online psych np programs, which train nurses to specialize in psychiatric and mental health care.

Additionally, health administration degrees online are a strategic choice for those aiming for leadership roles in hospitals, clinics, or public health organizations. These degrees offer a blend of management and healthcare knowledge to drive positive change in the industry.

Best Scientists Citing Douglas J. Veale

Trending Scientists